Literature DB >> 19960898

Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma.

Diane Rottembourg1, Clodagh S O'Gorman, Stacey Urbach, Pierre Y Garneau, Jacob C Langer, Guy Van Vliet, Jill Hamilton, Céline Huot.   

Abstract

Treatment of craniopharyngioma (CP) in childhood can lead to severe, debilitating obesity with devastating medical and psychological outcomes. Despite sustained nutritional and exercise-oriented interventions, no efficacious medical option is available for hypothalamic obesity. We describe two adolescents who developed morbid obesity and significant comorbidities following diagnosis and treatment of CP, in whom bariatric surgery was achieved, illustrating a novel approach for symptomatic hypothalamic obesity, as well as positive and negative outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19960898     DOI: 10.1515/jpem.2009.22.9.867

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  12 in total

Review 1.  Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up.

Authors:  Hermann L Müller
Journal:  Nat Rev Endocrinol       Date:  2010-09-28       Impact factor: 43.330

Review 2.  Risk-adapted, long-term management in childhood-onset craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

3.  Presence of CC Genotype for rs17773430 Could Affect the Percentage of Excess Weight Loss 1 Year After Bariatric Surgery: Tehran Obesity Treatment Study (TOTS).

Authors:  Niloufar Javanrouh; Alireza Khalaj; Kamran Guity; Bahareh Sedaghati-Khayat; Majid Valizadeh; Maryam Barzin; Maryam S Daneshpour
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

Review 4.  Childhood craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

5.  Hyperphagia: current concepts and future directions proceedings of the 2nd international conference on hyperphagia.

Authors:  Steven B Heymsfield; Nicole M Avena; Leslie Baier; Phillip Brantley; George A Bray; Lisa C Burnett; Merlin G Butler; Daniel J Driscoll; Dieter Egli; Joel Elmquist; Janice L Forster; Anthony P Goldstone; Linda M Gourash; Frank L Greenway; Joan C Han; James G Kane; Rudolph L Leibel; Ruth J F Loos; Ann O Scheimann; Christian L Roth; Randy J Seeley; Val Sheffield; Maïthé Tauber; Christian Vaisse; Liheng Wang; Robert A Waterland; Rachel Wevrick; Jack A Yanovski; Andrew R Zinn
Journal:  Obesity (Silver Spring)       Date:  2014-02       Impact factor: 5.002

Review 6.  Late endocrine effects of childhood cancer.

Authors:  Susan R Rose; Vincent E Horne; Jonathan Howell; Sarah A Lawson; Meilan M Rutter; Gylynthia E Trotman; Sarah D Corathers
Journal:  Nat Rev Endocrinol       Date:  2016-04-01       Impact factor: 43.330

7.  Duodenal-jejunal bypass restores insulin action and βeta-cell function in hypothalamic-obese rats.

Authors:  Maria Lúcia Bonfleur; Rosane Aparecida Ribeiro; Audrei Pavanello; Raul Soster; Camila Lubaczeuski; Allan Cezar Faria Araujo; Antonio Carlos Boschero; Sandra Lucinei Balbo
Journal:  Obes Surg       Date:  2015-04       Impact factor: 4.129

8.  Hypothalamic Obesity: 4 Years of the International Registry of Hypothalamic Obesity Disorders.

Authors:  Susan R Rose; Vincent E Horne; Nathan Bingham; Todd Jenkins; Jennifer Black; Thomas Inge
Journal:  Obesity (Silver Spring)       Date:  2018-10-08       Impact factor: 5.002

9.  Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity.

Authors:  Jiska van Schaik; Dominique G A Begijn; Laura van Iersel; Yvonne Vergeer; Eelco W Hoving; Babette Peeters; Hanneke M van Santen
Journal:  Obes Facts       Date:  2020-08-11       Impact factor: 3.942

10.  Long term sequelae of pediatric craniopharyngioma - literature review and 20 years of experience.

Authors:  Michal Cohen; Sharon Guger; Jill Hamilton
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-28       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.